Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
43.23 Down 0.53(1.21%) May 22, 4:00PM EDT
|After Hours : 44.40 Up 1.17 (2.71%) May 22, 7:15PM EDT
Add to Portfolio
Prev Close:43.76
Open:43.85
Bid:39.00 x 100
Ask:44.55 x 200
1y Target Est:44.64
Beta:2.36
Earnings Date:Jul 29 - Aug 3 (Est.)
Day's Range:42.80 - 44.39
52wk Range:30.05 - 44.95
Volume:874,308
Avg Vol (3m):1,170,510
Market Cap:5.40B
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENDown 1.21%5.40B
IMGNUp 0.79%766.18M
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.77
Quarterly EPS Est (Jun-15) :-0.21
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-3.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback